Pharmacokinetic simulations for remdesivir and its metabolites in healthy subjects and patients with renal impairment
IntroductionRemdesivir (RDV) is used for treating COVID-19 patients. This study aims to utilize an in silico pharmacokinetics model to simulate the pharmacokinetics of RDV, its intermediate metabolites (IM), and nucleoside monophosphate (NUC) in both healthy individuals and patients with renal impai...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1488961/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|